StonvexLoading…
StonvexStonvexStonvexCore line items from AHCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $819.80M | $3.24B | $2.40B | $1.58B |
Operating Income | $5.49M | $90.87M | $164.15M | $102.42M |
Net Income | $-16.04M | $-70.79M | $31.98M | $7.47M |
EPS (Diluted) | $-0.12 | $-0.52 | $0.21 | $0.05 |
Total Assets | $4.42B | $4.32B | $4.38B | $4.35B |
Total Liabilities | $2.91B | $2.79B | $2.76B | $2.76B |
Cash & Equivalents | $47.96M | $106.14M | $80.36M | $68.63M |
Free Cash Flow OCF − CapEx | $-27.49M | $219.38M | $140.09M | $73.27M |
Shares Outstanding | 136.01M | 135.45M | 135.42M | 135.22M |